FDA Clearance of First Pediatric OTC Continuous Glucose Monitor Expands Diagnostic Access

Summary

The FDA has approved the first over-the-counter continuous glucose monitor for children aged two and older. This clearance democratizes metabolic tracking for families, moving pediatric glucose monitoring from strictly clinical prescription models to direct-to-consumer retail availability.

The launch adds another node to the Diagnostics and Devices lane of the map. Distribution footprint, pricing, and access channels are the operator-relevant read.

Sources

• OVUM Primary source